Literature DB >> 32029688

Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis.

Richard Y Ebright1, Sooncheol Lee1, Ben S Wittner1, Kira L Niederhoffer1, Benjamin T Nicholson1, Aditya Bardia1,2, Samuel Truesdell1, Devon F Wiley1, Benjamin Wesley1, Selena Li1, Andy Mai1, Nicola Aceto1, Nicole Vincent-Jordan1, Annamaria Szabolcs1, Brian Chirn1, Johannes Kreuzer1, Valentine Comaills1, Mark Kalinich1, Wilhelm Haas1,2, David T Ting1,2, Mehmet Toner3,4,5, Shobha Vasudevan1,2, Daniel A Haber6,2,7, Shyamala Maheswaran6,5, Douglas S Micalizzi1,2.   

Abstract

Circulating tumor cells (CTCs) are shed into the bloodstream from primary tumors, but only a small subset of these cells generates metastases. We conducted an in vivo genome-wide CRISPR activation screen in CTCs from breast cancer patients to identify genes that promote distant metastasis in mice. Genes coding for ribosomal proteins and regulators of translation were enriched in this screen. Overexpression of RPL15, which encodes a component of the large ribosomal subunit, increased metastatic growth in multiple organs and selectively enhanced translation of other ribosomal proteins and cell cycle regulators. RNA sequencing of freshly isolated CTCs from breast cancer patients revealed a subset with strong ribosome and protein synthesis signatures; these CTCs expressed proliferation and epithelial markers and correlated with poor clinical outcome. Therapies targeting this aggressive subset of CTCs may merit exploration as potential suppressors of metastatic progression.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32029688      PMCID: PMC7307008          DOI: 10.1126/science.aay0939

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  62 in total

Review 1.  Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia.

Authors:  Yasmin Rosshandler; Ann Q Shen; Jorge Cortes; Hanna Jean Khoury
Journal:  Expert Rev Hematol       Date:  2016-04-21       Impact factor: 2.929

2.  Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis.

Authors:  Rajiv K Khajuria; Mathias Munschauer; Jacob C Ulirsch; Claudia Fiorini; Leif S Ludwig; Sean K McFarland; Nour J Abdulhay; Harrison Specht; Hasmik Keshishian; D R Mani; Marko Jovanovic; Steven R Ellis; Charles P Fulco; Jesse M Engreitz; Sabina Schütz; John Lian; Karen W Gripp; Olga K Weinberg; Geraldine S Pinkus; Lee Gehrke; Aviv Regev; Eric S Lander; Hanna T Gazda; Winston Y Lee; Vikram G Panse; Steven A Carr; Vijay G Sankaran
Journal:  Cell       Date:  2018-03-15       Impact factor: 41.582

3.  20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Authors:  Hongchao Pan; Richard Gray; Jeremy Braybrooke; Christina Davies; Carolyn Taylor; Paul McGale; Richard Peto; Kathleen I Pritchard; Jonas Bergh; Mitch Dowsett; Daniel F Hayes
Journal:  N Engl J Med       Date:  2017-11-09       Impact factor: 91.245

4.  Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition.

Authors:  Min Yu; Aditya Bardia; Ben S Wittner; Shannon L Stott; Malgorzata E Smas; David T Ting; Steven J Isakoff; Jordan C Ciciliano; Marissa N Wells; Ajay M Shah; Kyle F Concannon; Maria C Donaldson; Lecia V Sequist; Elena Brachtel; Dennis Sgroi; Jose Baselga; Sridhar Ramaswamy; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Science       Date:  2013-02-01       Impact factor: 47.728

5.  U2504 determines the species specificity of the A-site cleft antibiotics: the structures of tiamulin, homoharringtonine, and bruceantin bound to the ribosome.

Authors:  Güliz Gürel; Gregor Blaha; Peter B Moore; Thomas A Steitz
Journal:  J Mol Biol       Date:  2009-04-09       Impact factor: 5.469

6.  Polysome analysis of mammalian cells.

Authors:  Shan L He; Rachel Green
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

Review 7.  Ribosome biogenesis in cancer: new players and therapeutic avenues.

Authors:  Joffrey Pelletier; George Thomas; Siniša Volarević
Journal:  Nat Rev Cancer       Date:  2017-12-01       Impact factor: 60.716

8.  MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes.

Authors:  Graeme C McAlister; David P Nusinow; Mark P Jedrychowski; Martin Wühr; Edward L Huttlin; Brian K Erickson; Ramin Rad; Wilhelm Haas; Steven P Gygi
Journal:  Anal Chem       Date:  2014-07-03       Impact factor: 8.008

Review 9.  Tumor cell dormancy.

Authors:  Roger R Gomis; Sylwia Gawrzak
Journal:  Mol Oncol       Date:  2016-10-07       Impact factor: 6.603

10.  HER2 expression identifies dynamic functional states within circulating breast cancer cells.

Authors:  Nicole Vincent Jordan; Aditya Bardia; Ben S Wittner; Cyril Benes; Matteo Ligorio; Yu Zheng; Min Yu; Tilak K Sundaresan; Joseph A Licausi; Rushil Desai; Ryan M O'Keefe; Richard Y Ebright; Myriam Boukhali; Srinjoy Sil; Maristela L Onozato; Anthony J Iafrate; Ravi Kapur; Dennis Sgroi; David T Ting; Mehmet Toner; Sridhar Ramaswamy; Wilhelm Haas; Shyamala Maheswaran; Daniel A Haber
Journal:  Nature       Date:  2016-08-24       Impact factor: 49.962

View more
  71 in total

1.  Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients.

Authors:  Liu Yang; Xiaowei Yan; Jie Chen; Qiong Zhan; Yingqi Hua; Shili Xu; Ziming Li; Zhuo Wang; Yu Dong; Dongqing Zuo; Min Xue; Yin Tang; Harvey R Herschman; Shun Lu; Qihui Shi; Wei Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

Review 2.  Liquid biopsy enters the clinic - implementation issues and future challenges.

Authors:  Michail Ignatiadis; George W Sledge; Stefanie S Jeffrey
Journal:  Nat Rev Clin Oncol       Date:  2021-01-20       Impact factor: 66.675

Review 3.  Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.

Authors:  Xianglei Fu; Yanbin Shi; Tongtong Qi; Shengnan Qiu; Yi Huang; Xiaogang Zhao; Qifeng Sun; Guimei Lin
Journal:  Signal Transduct Target Ther       Date:  2020-11-06

Review 4.  Exploring liver cancer biology through functional genetic screens.

Authors:  Cun Wang; Ying Cao; Chen Yang; René Bernards; Wenxin Qin
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-23       Impact factor: 46.802

Review 5.  Genome-editing approaches and applications: a brief review on CRISPR technology and its role in cancer.

Authors:  Narmadhaa Siva; Sonal Gupta; Ayam Gupta; Jayendra Nath Shukla; Babita Malik; Nidhi Shukla
Journal:  3 Biotech       Date:  2021-02-26       Impact factor: 2.406

6.  Context-specific action of macrolide antibiotics on the eukaryotic ribosome.

Authors:  Maxim S Svetlov; Timm O Koller; Sezen Meydan; Vaishnavi Shankar; Dorota Klepacki; Norbert Polacek; Nicholas R Guydosh; Nora Vázquez-Laslop; Daniel N Wilson; Alexander S Mankin
Journal:  Nat Commun       Date:  2021-05-14       Impact factor: 14.919

7.  PNO1 regulates autophagy and apoptosis of hepatocellular carcinoma via the MAPK signaling pathway.

Authors:  Zhiqiang Han; Dongming Liu; Lu Chen; Yuchao He; Xiangdong Tian; Lisha Qi; Liwei Chen; Yi Luo; Ziye Chen; Xiaomeng Hu; Guangtao Li; Linlin Zhan; Yu Wang; Qiang Li; Peng Chen; Zhiyong Liu; Hua Guo
Journal:  Cell Death Dis       Date:  2021-05-28       Impact factor: 8.469

8.  Octahedral silver oxide nanoparticles enabling remarkable SERS activity for detecting circulating tumor cells.

Authors:  Meng He; Jie Lin; Ozioma Udochukwu Akakuru; Xiawei Xu; Yanying Li; Yi Cao; Yanping Xu; Aiguo Wu
Journal:  Sci China Life Sci       Date:  2021-07-08       Impact factor: 6.038

9.  A trans locus causes a ribosomopathy in hypertrophic hearts that affects mRNA translation in a protein length-dependent fashion.

Authors:  Franziska Witte; Jorge Ruiz-Orera; Camilla Ciolli Mattioli; Susanne Blachut; Eleonora Adami; Jana Felicitas Schulz; Valentin Schneider-Lunitz; Oliver Hummel; Giannino Patone; Michael Benedikt Mücke; Jan Šilhavý; Matthias Heinig; Leonardo Bottolo; Daniel Sanchis; Martin Vingron; Marina Chekulaeva; Michal Pravenec; Norbert Hubner; Sebastiaan van Heesch
Journal:  Genome Biol       Date:  2021-06-28       Impact factor: 13.583

Review 10.  Translational control of stem cell function.

Authors:  James A Saba; Kifayathullah Liakath-Ali; Rachel Green; Fiona M Watt
Journal:  Nat Rev Mol Cell Biol       Date:  2021-07-16       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.